Picard, S. Trough imatinib plasma levels are associated with both cytogenetic and moleci^ar responses to standard-dose imatinib in chronic myeloid leukemic. Blood. 2007, 109, 3496-3499
Larson, RA. IRIS (International Randomized Interferon vs STI571) Study Group. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanal-ysis of the IRIS study. Blood. 2008, 111, 4022-4028
Singh, N. Drug monitoring of imatinib levels in patients undergoing therapy for chronic myeloid leukaemia: comparing plasma levels of resgftnders and non-responders. Eur J Clin Pharmacol. 2009, 65, 545-549